FT Asia Healthcare and Life Sciences Summit is organized by Financial Times Live and would be held on May 25, 2016 at The Westin, DownTowncore, Singapore, Singapore.
The healthcare and life sciences industry is continuing to expand in Asia, in tandem with evolving patient needs that are influenced by higher incomes, longer life expectancy, population growth and changing lifestyles. Alongside private companies, governments in the region have been investing more vigorously in healthcare infrastructure and services. The increase in public and private healthcare spending has in turn boosted the pharmaceuticals and biotech industry. Opportunities abound for global companies, as well as their local counterparts.
But capitalising on the region’s burgeoning market is not without many challenges. For a start, competition has intensified as global pharmaceuticals firms shift manufacturing operations to lower-cost Asia even as domestic drugs companies increase in number and size. Differing regulations across Asia, inadequate distribution facilities and low pricing are other headaches, as is the surge in counterfeit medicine and theft of research. On the other hand, the potential for collaboration between local and foreign companies is promising, especially as several major drugs are now off patent. Asia also has become important as a research and development centre for some of the biggest international players.
Clearly, doing well in the region’s market greatly benefits corporate global performance. FT Asia Healthcare & Life Sciences Summit: Forging frontiers for pharmaceuticals gathers together chief executive officers, chief medical officers and other senior business leaders to examine the latest developments in healthcare, pharmaceuticals and biotech across Asia.
Prices :
Early Bird: USD 795
Standard: USD 995
Speakers: Xudong Yin, Benjamin Seet, Deborah Elms, Carl Firth, Victoria Elegant, Xian-Ping Lu, Christian Hogg, Amit Backliwal, Srividya Jagannathan, Samson Chiu, Cyril Grandchamp-Desraux, Hideo Arase